Neuberger Berman Group
HZNP

Neuberger Berman Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Neuberger Berman Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-173,122
Closed -$20M – 1952
2023
Q3 		$20M Sell
173,122
-95,215
-35% -$10.2M 0.02% 599
2023
Q2 		$27.6M Sell
268,337
-62,987
-19% -$6.65M 0.02% 542
2023
Q1 		$36.2M Sell
331,324
-368,842
-53% -$40.8M 0.03% 491
2022
Q4 		$79.7M Sell
700,166
-818,874
-54% -$68M 0.08% 305
2022
Q3 		$94M Buy
1,519,040
+1,038,577
+216% +$72.6M 0.1% 272
2022
Q2 		$38.3M Buy
480,463
+106,156
+28% +$10.1M 0.04% 485
2022
Q1 		$39.4M Buy
374,307
+29,377
+9% +$2.86M 0.03% 524
2021
Q4 		$37.1M Sell
344,930
-92,389
-21% -$10.1M 0.03% 551
2021
Q3 		$47.8M Buy
437,319
+101
+0% +$10.5K 0.04% 473
2021
Q2 		$40.9M Buy
437,218
+6,034
+1% +$555K 0.04% 517
2021
Q1 		$39.6M Sell
431,184
-17,799
-4% -$1.5M 0.04% 508
2020
Q4 		$32.8M Buy
448,983
+101,930
+29% +$7.58M 0.03% 520
2020
Q3 		$27M Buy
347,053
+89,303
+35% +$6.14M 0.03% 505
2020
Q2 		$14.3M Buy
257,750
+177,750
+222% +$7.6M 0.02% 648
2020
Q1 		$2.37M Buy
80,000
+7,100
+10% +$240K ﹤0.01% 910
2019
Q4 		$2.64M Hold
72,900
– – ﹤0.01% 969
2019
Q3 		$1.99M Buy
+72,900
New +$1.88M ﹤0.01% 1012
2018
Q3 		– Sell
-20,000
Closed -$331K – 1741
2018
Q2 		$331K Buy
+20,000
New +$305K ﹤0.01% 1481
2017
Q3 		– Sell
-602,070
Closed -$7.15M – 1667
2017
Q2 		$7.15M Buy
+602,070
New +$7.49M 0.01% 805
2014
Q4 		– Sell
-11,785
Closed -$144K – 1723
2014
Q3 		$144K Sell
11,785
-840,050
-99% -$9.76M ﹤0.01% 1603
2014
Q2 		$13.5M Buy
851,835
+250,085
+42% +$3.57M 0.01% 763
2014
Q1 		$9.1M Buy
+601,750
New +$6.8M 0.01% 820

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Neuberger Berman Group's HZNP Position: Q4 2023 in Review

Neuberger Berman Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 173,122 shares — an estimated $20M sold.

Neuberger Berman Group first reported a position in HZNP in Q1 2014 and held it in 22 quarters. The position peaked at $94M in Q3 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Neuberger Berman Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Neuberger Berman Group sold 173,122 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $20M.
  • Neuberger Berman Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2014 and held it in 22 quarters.
  • Neuberger Berman Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $94M in Q3 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Neuberger Berman Group's 13F filing for Q4 2023, filed 9 Feb 2024.